어넥사 테라퓨틱스ERNA 주가

Ernexa Therapeutics Announces Progress In Development Of ERNA-101; Hits Multiple Milestones Ahead Of Planned IND Submission In Q3 2026 And First‑In‑Human Study Initiation

Ernexa Therapeutics (NASDAQ:ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced significant progress in the development of ERNA-101,

♻️ 재탕[SCHEDULE 13G/A] SCHEDULE 13G/A

Here are the top movers in Friday's session.

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

♻️ 재탕12 Health Care Stocks Moving In Friday's Intraday Session

♻️ 재탕[SCHEDULE 13G/A] SCHEDULE 13G/A

♻️ 재탕[SCHEDULE 13G/A] SCHEDULE 13G/A

♻️ 재탕[SCHEDULE 13G] SCHEDULE 13G

♻️ 재탕[SCHEDULE 13G] SCHEDULE 13G

[SCHEDULE 13G/A] SCHEDULE 13G/A

Which stocks are moving on Tuesday?

Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.